Corrigendum to “Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer” [Lung Cancer 123 (2018) 36–43]
The authors regret that there was an error in the labelling of plasmid K78I. All the cell lines containing mutant LKB1 should be labelled K78I, not K78 M, throughout this article.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Fakeng Liu, Yuan Liu, Xiuju Liu, Kaisheng Mao, Diansheng Zhong, Adam I. Marcus, Fadlo R. Khuri, Shi-Yong Sun, Yulong He, Wei Zhou Tags: Corrigendum Source Type: research